The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.
Takeda Pharmaceuticals North America, Inc. (TPNA) announced that the company will revise warnings related to congestive heart failure (CHF) in the prescribing label of its type 2 diabetes medication ACTOS(R) (pioglitazone HCl).
Talcum powder has been used for generations to soothe babies? diaper rash and freshen women?s faces. But University of Florida researchers report the household product has an additional healing power: The ability to stunt cancer growth by cutting the flow of blood to metastatic lung tumors.
Children of overweight or single mothers have a greater likelihood of being overweight or obese, new research has found.
New research indicates that folic acid supplementation does not decrease the risk of benign colorectal tumors, but may possibly increase the risk for some types of colorectal tumors, according to a study in the June 6 issue of JAMA.
Why does the same diet make some of us gain more weight than others? The answer could be a molecule called Bsx, as scientists from the European Molecular Biology Laboratory (EMBL), the German Institute for Nutrition (DIFE), Potsdam, and the University of Cincinnati report in the current issue of Cell Metabolism. Bsx is the molecular link between spontaneous physical activity and food intake.
Otsuka Pharmaceutical Co, Ltd., and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority (six month review target) review the supplemental New Drug Application (sNDA) of the atypical antipsychotic ABILIFY? (aripiprazole) for the treatment of pediatric patients (13-17 years old) with schizophrenia.
CSIRO scientists have joined the battle to save Australia?s iconic Tasmanian devils from the deadly cancer currently devastating devil populations.
The U.S. Department of Health and Human Services (HHS) has awarded a contract to Bavarian Nordic for the manufacture and delivery of 20 million doses of the company?s MVA based smallpox vaccine, IMVAMUNE?, for the protection of persons considered to be at risk for smallpox.
The U.S. Food and Drug Administration (FDA) today announced a new advisory committee designed to counsel the agency on how to strengthen the communication of risks and benefits of FDA-regulated products to the public.